Beyond Innovation: Lessons from the 2026 Women’s Health Innovation Summit
What the next phase of women’s health will require from companies and their leaders
- Home
- Perspectives
- Beyond Innovation: Lessons from the 2026 Women’s Health Innovation Summit
Innovation in women’s health continues to accelerate, with growing attention to conditions that have historically been underserved. That momentum was evident last month in Boston at the Women’s Health Innovation Summit (WHIS). The conversations at WHIS also highlighted the barriers that continue to stand between innovation and wider access. Reimbursement remains a significant challenge, women’s healthcare continues to be fragmented, and the leadership capabilities in this increasingly complex environment are evolving. For organizations operating in women’s health, the opportunity is growing, yet realizing it will require more than bringing new products and services to market. Companies must also address how those solutions are paid for, connected, and delivered.
Getting innovation paid for and adopted
One of the key themes at WHIS was that innovation alone will not expand access to women’s healthcare. Even solutions that demonstrate consumer demand and clinical value can struggle if insurers will not cover them, or employers and health systems will not adopt them. These challenges have helped drive the growth of self-pay, employer-sponsored, and direct-to-consumer models, an evolution we have explored in previous WittKieffer work (The self-pay pathway, a strategic bridge between innovation and reimbursement in US healthcare).
As companies look to reach more women, they face a strategic question: whether to continue building outside traditional reimbursement, build toward eventual payer adoption, or pursue both. That choice influences the evidence companies need to generate, the partnerships they pursue, and how they go to market. It also raises the leadership bar. Companies need executives who understand how payers and providers make decisions and can translate clinical and commercial evidence into a compelling case for coverage and adoption.
Moving from standalone solutions to connected care
WHIS also highlighted the need to move from individual solutions toward more connected women’s healthcare. Investment and innovation in the sector are expanding beyond their traditional focus on reproductive and maternal health to include menopause, cardiometabolic health, behavioral health, and chronic disease. Yet many of these services continue to operate separately, while women move between different providers and solutions across their lives. As the sector develops, success will increasingly depend on how effectively organizations integrate with the broader healthcare system rather than on how many services they provide themselves. That places greater emphasis on partnerships and on understanding how an organization’s solution fits within a woman’s overall care. The leadership implications are significant: executives need to bridge consumer health and traditional healthcare, work across specialties, and build relationships across organizations that have historically operated independently.
Has the leadership profile kept pace?
The experience that helped build women’s health companies may not be sufficient for their next phase. Securing reimbursement, gaining adoption within health systems, and connecting services across the wider healthcare system call for different capabilities. Organizations increasingly need leaders who have successfully navigated payer strategy, market access, and evidence generation; understand provider economics, clinical workflows, and enterprise purchasing decisions; and know how to build partnerships and integrated care models across organizational boundaries. For some companies, leaders must also be able to bridge the different demands of consumer health and traditional healthcare.
Yet organizations may still treat deep women’s health experience as the defining leadership requirement, rather than starting with the barriers now limiting the business. The relatively small pool of established sector leaders makes that approach harder to sustain. The more important question is whether the leadership profile has evolved alongside the business. Companies may need to look beyond women’s health for executives with capabilities that match the challenges the business now needs to address.
Women’s health organizations with leaders who can navigate the healthcare system will be better positioned to address its limitations and help change it from within. By demonstrating value, gaining adoption, and building models that can scale, they can help bring promising innovations into mainstream care. Without that leadership capability, valuable solutions risk remaining at the edges of healthcare, never realizing their full potential.
